The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism
Pharmacology Biochemistry and Behavior · 2023
DOI: 10.1016/j.pbb.2023.173530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2023. Verfasst von David B Finlay und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. Electronic address: david.finlay@o…. Hauptthemen laut MEDLINE: Cannabinoid Receptor Agonists, Cannabinoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institutes of Health, National Institute on Drug Abuse.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology & Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. Electronic address: david.finlay@otago.ac.nz.
- Department of Pharmacology & Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
- RTI International, Research Triangle Park, NC, USA.
Förderung
- NIDA NIH HHS
- National Institutes of Health
- National Institute on Drug Abuse
- Health Research Council of New Zealand
Zitieren
APA
Finlay, D. B., Mackie, W., Webb, H. D. J., Thomsen, L. R., Nimick, M., Rosengren, R. J., Marusich, J. A., Glass, M., & Wiley, J. L. (2023). The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2023.173530
Vancouver
Finlay DB, Mackie W, Webb HDJ, Thomsen LR, Nimick M, Rosengren RJ, et al. The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism. Pharmacology Biochemistry and Behavior. 2023. doi:10.1016/j.pbb.2023.173530
BibTeX
@article{Finlay2023,
author = {Finlay, David B and Mackie, Warwick and Webb, Hunter D J and Thomsen, Lucy R and Nimick, Mhairi and Rosengren, Rhonda J and Marusich, Julie A and Glass, Michelle and Wiley, Jenny L},
title = {The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism},
journal = {Pharmacology Biochemistry and Behavior},
year = {2023},
doi = {10.1016/j.pbb.2023.173530}
}
EUVIMED